Dapsone: unapproved uses or indications.
Wolf
R
R
Department of Dermatology, Tel-Aviv Sourasky Medical Center, Ichilov Hospital, Israel.
Tüzün
B
B
Tüzün
Y
Y
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003622:Dapsone / Q000494:pharmacology / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D017277:Drug Approval; D004363:Drug Utilization; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D012871:Skin Diseases / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; D003622:Dapsone